In contrast, discriminating KMT2A-r and MECOM-r cases from MLLT3- and GATA2- rearranged cases and accepting only specific partner genes according to ICC did not show differences regarding OS neither within rearranged cases nor compared to WHO 2022. Here, GATA2 is linked to intrahepatic cholangiocarcinoma.